EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Genomics in Pancreas–Kidney Transplantation: From Risk Stratification to Personalized Medicine

Hande Aypek iD, Ozan Aygormez iD, Yasar Caliskan iD

Genes · 2025

DOI: 10.3390/genes16080884 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2025. Verfasst von Hande Aypek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Bursa Uludag University School of Medicine, Bursa 16059, Türkiye. Hauptthemen laut MEDLINE: Kidney Transplantation, Pancreas Transplantation, Precision Medicine, Genomics. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreas and pancreas–kidney transplantation are well-established therapeutic options for patients with type 1 diabetes mellitus (T1DM) and end-stage kidney disease (ESKD), offering the potential to restore endogenous insulin production and kidney function. It improves metabolic control, quality of life, and long-term survival. While surgical techniques and immunosuppressive strategies have advanced considerably, graft rejection and limited long-term graft survival remain significant clinical challenges.

Method

To better understand these risks, the genetic and immunological factors that influence transplant outcomes are examined. Beyond traditional human leukocyte antigen (HLA) matching, non-HLA genetic variants such as gene deletions and single-nucleotide polymorphisms (SNPs) have emerged as contributors to alloimmune activation and graft failure.

Result

Polymorphisms in cytokine genes, minor histocompatibility antigens, and immune-regulatory pathways have been implicated in transplant outcomes. However, the integration of such genomic data into clinical practice remains limited due to underexplored gene targets, variability in study results, and the lack of large, diverse, and well-characterized patient cohorts. Initiatives like the International Genetics & Translational Research in Transplantation Network (iGeneTRAiN) are addressing these limitations by aggregating genome-wide data from thousands of transplant donors and recipients across multiple centers. These large-scale collaborative efforts aim to identify clinically actionable genetic markers and support the development of personalized immunosuppressive strategies.

Conclusions

Overall, genetic testing and genomics hold great promise in advancing precision medicine in pancreas and pancreas–kidney transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationPancreas TransplantationPrecision MedicineGenomicsDiabetes Mellitus, Type 1Kidney Failure, ChronicHumansPolymorphism, Single NucleotideRisk AssessmentGraft RejectionGraft SurvivalHLA Antigens

Stichwörter der Autor:innen

genomicsnon-HLA geneticspancreas transplantationsimultaneous pancreas–kidney (SPK) transplantation

Substanzen

HLA Antigens

Autor:innen und Institutionen

  • Division of Nephrology, Bursa Uludag University School of Medicine, Bursa 16059, Türkiye.
  • Division of Nephrology, Istanbul Faculty of Medicine, Istanbul University, Istanbul 34093, Türkiye.
  • Division of Abdominal Transplant, SSM Health Saint Louis University Hospital, Saint Louis, MO 63104, USA.

ORCID-Profile: Hande Aypek, Ozan Aygormez, Yasar Caliskan

Zitieren

APA

Aypek, H., Aygormez, O., & Caliskan, Y. (2025). Genomics in Pancreas–Kidney Transplantation: From Risk Stratification to Personalized Medicine. Genes. https://doi.org/10.3390/genes16080884

Vancouver

Aypek H, Aygormez O, Caliskan Y. Genomics in Pancreas–Kidney Transplantation: From Risk Stratification to Personalized Medicine. Genes. 2025. doi:10.3390/genes16080884

BibTeX
@article{Aypek2025,
  author = {Aypek, Hande and Aygormez, Ozan and Caliskan, Yasar},
  title = {Genomics in Pancreas–Kidney Transplantation: From Risk Stratification to Personalized Medicine},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16080884}
}
Kostenlos starten →